Enhertu now approved in Japan for gastric cancer
Enhertu from Daiichi-Sankyo is now approved in Japan for the treatment of HER2-positive gastric cancer.
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org